Ethics of COVID-19 vaccination in children with Dr Ros Jones (Retired Pediatrician)

Children were less impacted by COVID-19 compared to adults, leading to concerns about healthcare system capacity. • 1:31

Retired pediatrician was psychologically prepared to return to frontline work during the pandemic. • 3:15

Initial surreal atmosphere during the early stages of the pandemic. • 5:20

Healthcare system faced challenges with increasing intensive care numbers and resource allocation. • 5:41

Children’s ward was almost converted to an additional intensive care unit due to rising cases. • 6:11

Diabetic children were avoiding hospital visits during the peak of the pandemic. • 6:33

The situation eventually stabilized, leading to a decrease in pediatric cases and a return to normalcy. • 6:45

Hospital resources were reallocated to address the surge in adult COVID-19 cases. • 6:53

Initial guidance for over 70s to stay indoors for 12 weeks. • 6:50

Variability in school reopening decisions during the pandemic. • 7:16

Challenges in transitioning surgical theaters back to normal use. • 8:06

Delay in catching up with medical backlogs due to pandemic disruptions. • 8:25

Consideration of intentionally exposing children to achieve herd immunity. • 8:37

Studies showing lower COVID-19 risk for teachers and healthcare workers with children. • 9:32

Initial exclusion of children from vaccination program; surprise at children’s trial. • 11:23

Assurance from vaccine expert on safety evaluation before child vaccination rollout. • 11:50

Confirmation that COVID-19 vaccine rollout for children was not expected within a year. • 12:13

Dr. Ros Jones joined a group of scientists in January 2021 to provide a different perspective on COVID-19 data and advice. • 15:03

The group included various experts such as pediatricians, ethicists, and public health consultants. • 15:33

The group aimed to offer a balanced view of COVID-19 management, focusing on broader disciplines than the government’s advisory team. • 15:40

Their efforts included analyzing the impacts of lockdowns, masks, and other measures on children’s well-being. • 16:03

Despite sending weekly bulletins and position statements to MPs, the group’s advice was mostly ignored by central government. • 16:38

The government may have viewed the group as a fringe opinion rather than a valuable source of advice. • 17:34

The group also engaged in discussions regarding the ethics of COVID-19 vaccination in children with regulatory bodies like the MHRA and JCVI. • 17:59

Science should involve open debate and discussion to prevent becoming dogmatic in its approach. • 18:14

Massive censorship and job loss for speaking out against COVID-19 measures. • 18:22

Concerns about lack of informed consent and conflicts of interest in academia. • 21:26

Fear and pressure leading to silence among medical professionals. • 23:21

Vaccine mandates in NHS causing division among age groups. • 23:54

Questioning the necessity of COVID-19 vaccination after natural immunity • 24:18

Concerns about consistent messaging in public health vs. questioning procedures • 24:24

Comparison of COVID-19 vaccine to traditional vaccines and its experimental nature • 26:03

Deceptive tactics in promoting COVID-19 vaccination • 26:28

Legal implications and coercion for COVID-19 vaccination in certain countries • 27:26

Risk assessment for different age groups in relation to COVID-19 vaccination • 28:32

Differences in technology and perception of COVID-19 vaccine compared to traditional vaccines • 29:54

mRNA technology is new and untested in humans • 30:18

Uncertainty in dosage and antigen levels with mRNA vaccines • 30:41

Concerns about biodistribution of lipid nanoparticles in the body • 31:36

UK government acknowledges uncertainty in impact of vaccination for children • 33:38

Focus on potential future waves rather than current COVID-19 situation • 34:05

Consideration of wider implications such as education and missed school days • 34:32

Questioning the necessity of vaccinating children based on school attendance • 35:00

Low percentage of children actually contracting COVID-19 in school settings • 35:38

Changes in isolation rules due to minimal transmission in school environments • 36:06

Schools not following guidelines on isolating children, causing unnecessary disruption. • 36:12

Modeling on vaccination benefits did not consider children who had already had COVID-19. • 36:39

Concerns raised about the psychological impact and side effects of vaccines in children. • 37:39

Higher risk of myocarditis in adolescents after the second dose of Pfizer vaccine. • 38:57

Data from Israel and Hong Kong show varying rates of myocarditis post-vaccination. • 39:02

Hong Kong discontinued second doses due to higher risk of myocarditis. • 40:16

Prediction of increased myocarditis cases in 12-15 year olds if given second dose. • 40:33

Question raised on regulatory staff’s decision to vaccinate their own children. • 41:06

Histopathological examination showing fibrosis in muscle post-vaccination in adolescents. • 41:20

Inflammatory process occurred before the second dose, leading to deaths within four days • 41:39

High percentage of children showed evidence of heart muscle swelling and scarring post-vaccination • 43:03

Urgent need for thorough follow-up studies on children post-vaccination • 44:09

Risks of viral myocarditis in children and potential long-term implications • 46:57

Caution urged in rushing vaccination efforts for children without sufficient data • 47:09

COVID-19 vaccine safety concerns and adverse event reporting systems like VAERS and Yellow Card • 47:43

Significant increase in adverse event reports, including deaths, related to COVID-19 vaccines • 48:02

Emergency use authorization for vaccines in children questioned due to low risk • 48:28

Influence of pressure from governments and pharmaceutical companies on decision-making • 49:06

Conflict of interest issues within regulatory bodies and lack of separation from drug industry • 50:01

Challenges in post-marketing surveillance and reporting of vaccine adverse events • 51:36

Importance of proper age stratification in identifying vaccine-related adverse events • 53:08

Misquoted data on myocarditis risk post-COVID vs. post-vaccination, with age group variations. • 53:46

Importance of informed consent tailored to individual risk factors and relevant information. • 54:18

Concerns raised about potential long-term vaccine side effects being overlooked. • 54:30

All-cause mortality as a crucial metric for assessing vaccine efficacy and safety. • 55:06

Issue of excluding early adverse events from vaccine trial analyses. • 55:24

Disconnect between physicians and vaccine administration settings impacting informed consent. • 57:52

Transition from prioritizing vulnerable groups to achieving herd immunity timeline discussed. • 57:52

Lack of awareness among vaccine administrators about potential side effects like myocarditis. • 59:05

Concerns raised about underreporting or lack of vigilance for adverse events like myocarditis. • 59:23

Lack of proper communication and awareness among healthcare professionals about myocarditis risk in young adults • 59:37

Inadequate dissemination of information regarding vaccine risks and exemptions, leading to potentially harmful situations • 1:00:03

Misleading reasons being given to parents for vaccinating children, such as protecting vulnerable relatives and facilitating work or travel • 1:01:34

Emphasis on natural immunity in children and the effectiveness of their upper airway immunity, contrary to common misconceptions • 1:03:30

Government misinformation regarding vaccine safety and the importance of natural immunity, contributing to public confusion • 1:04:14

Evidence of long-term natural immunity against viruses like SARS-CoV-2 in children, highlighting the overlooked aspect of upper airway immunity • 1:05:00

Discussion on the oversight of mucosal upper airway immunity in decision-making. • 1:05:20

Concerns raised about the lack of expert immunologists in decision-making processes. • 1:05:36

Highlight on unlimited indemnity for drug companies in case of vaccine injuries. • 1:06:00

Observations on the neglected public health advice regarding vitamin D supplementation. • 1:08:00

Emphasis on the role of parental instincts in evaluating vaccination risks for children. • 1:11:02

Reminder to trust instincts when safeguarding children • 1:11:16

Importance of adults protecting children • 1:11:24

Appreciation for informative and inspiring discussion • 1:11:40

Outro thanking viewers and guest speaker • 1:11:48